Compare DMRA & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DMRA | GLP |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | 7 | 4700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2020 | N/A |
| Metric | DMRA | GLP |
|---|---|---|
| Price | $33.42 | $47.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $43.00 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 864.6K | 120.4K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 6.40% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $64.13 |
| Revenue Next Year | N/A | $11.74 |
| P/E Ratio | ★ N/A | $23.28 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.50 | $39.58 |
| 52 Week High | $34.89 | $53.25 |
| Indicator | DMRA | GLP |
|---|---|---|
| Relative Strength Index (RSI) | 67.41 | 49.88 |
| Support Level | $22.71 | $46.01 |
| Resistance Level | N/A | $48.48 |
| Average True Range (ATR) | 2.81 | 1.42 |
| MACD | 0.44 | 0.05 |
| Stochastic Oscillator | 84.06 | 41.25 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.